158 related articles for article (PubMed ID: 31986490)
1. Association between serum levels of Klotho and inflammatory cytokines in cardiovascular disease: a case-control study.
Martín-Núñez E; Donate-Correa J; Ferri C; López-Castillo Á; Delgado-Molinos A; Hernández-Carballo C; Pérez-Delgado N; Rodríguez-Ramos S; Cerro-López P; Tagua VG; Mora-Fernández C; Navarro-González JF
Aging (Albany NY); 2020 Jan; 12(2):1952-1964. PubMed ID: 31986490
[TBL] [Abstract][Full Text] [Related]
2. Klotho expression in peripheral blood circulating cells is associated with vascular and systemic inflammation in atherosclerotic vascular disease.
Martín-Núñez E; Pérez-Castro A; Tagua VG; Hernández-Carballo C; Ferri C; Pérez-Delgado N; Rodríguez-Ramos S; Cerro-López P; López-Castillo Á; Delgado-Molinos A; López-Tarruella VC; Arévalo-Gómez MA; González-Luis A; Martín-Olivera A; Morales-Estévez CC; Mora-Fernández C; Donate-Correa J; Navarro-González JF
Sci Rep; 2022 May; 12(1):8422. PubMed ID: 35590090
[TBL] [Abstract][Full Text] [Related]
3. Plasma klotho and cardiovascular disease in adults.
Semba RD; Cappola AR; Sun K; Bandinelli S; Dalal M; Crasto C; Guralnik JM; Ferrucci L
J Am Geriatr Soc; 2011 Sep; 59(9):1596-601. PubMed ID: 21883107
[TBL] [Abstract][Full Text] [Related]
4. U-shaped association between serum Klotho and all-cause mortality in US cardiovascular patients: a prospective cohort study.
Liu S; Zhu Z; Yu K; Zhang W; Pu J; Lv Y; Tang Z; Liu F; Sun Y
Front Endocrinol (Lausanne); 2024; 15():1405665. PubMed ID: 38948524
[TBL] [Abstract][Full Text] [Related]
5. The association between soluble klotho and cardiovascular parameters in chronic kidney disease: results from the KNOW-CKD study.
Kim HJ; Kang E; Oh YK; Kim YH; Han SH; Yoo TH; Chae DW; Lee J; Ahn C; Oh KH
BMC Nephrol; 2018 Mar; 19(1):51. PubMed ID: 29506503
[TBL] [Abstract][Full Text] [Related]
6. [Role of the morphogenetic proteins FGF-23 and Klotho and the glycoprotein sclerostin in the assessment of the risk of cardiovascular diseases and the prognosis of chronic kidney disease].
Milovanova LY; Milovanov YS; Kudryavtseva DV; Markina MM; Milovanova SY; Kozlovskaya LV; Lebedeva MV; Beketov VD; Moiseev SV; Mukhin NA; Fomin VV; Svistunov AA
Ter Arkh; 2015; 87(6):10-16. PubMed ID: 26281189
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factor 23 and Klotho as cardiovascular risk factors in heart transplant recipients.
Przybylowski P; Wasilewski G; Janik L; Kozlowska S; Nowak E; Malyszko J
Transplant Proc; 2014 Oct; 46(8):2848-51. PubMed ID: 25380933
[TBL] [Abstract][Full Text] [Related]
8. Serum Klotho, Cardiovascular Events, and Mortality in Nondiabetic Chronic Kidney Disease.
Yang K; Yang J; Bi X; Yu Z; Xiao T; Huang Y; Liu Y; Xiong J; Zhao J
Cardiorenal Med; 2020; 10(3):175-187. PubMed ID: 32294646
[TBL] [Abstract][Full Text] [Related]
9. Relationship of Serum Soluble Klotho Levels and Echocardiographic Parameters in Patients on Maintenance Hemodialysis.
Zhang AH; Guo WK; Yu L; Liu WH
Kidney Blood Press Res; 2019; 44(3):396-404. PubMed ID: 31079116
[TBL] [Abstract][Full Text] [Related]
10. Circulating Klotho Associates With Cardiovascular Morbidity and Mortality During Hemodialysis.
Marçais C; Maucort-Boulch D; Drai J; Dantony E; Carlier MC; Blond E; Genet L; Kuentz F; Lataillade D; Legrand E; Moreau-Gaudry X; Jean G; Fouque D;
J Clin Endocrinol Metab; 2017 Sep; 102(9):3154-3161. PubMed ID: 28402487
[TBL] [Abstract][Full Text] [Related]
11. [New markers of cardio-renal links in chronic kidney disease].
Milovanova LIu; Milovanov IuS; Kozlovskaia LV; Mukhin NA
Ter Arkh; 2013; 85(6):17-24. PubMed ID: 23866594
[TBL] [Abstract][Full Text] [Related]
12. Raised plasma total sialic acid levels are markers of cardiovascular disease in renal dialysis patients.
Afzali B; Bakri RS; Bharma-Ariza P; Lumb PJ; Dalton N; Turner NC; Wierzbicki AS; Crook MA; Goldsmith DJ
J Nephrol; 2003; 16(4):540-5. PubMed ID: 14696756
[TBL] [Abstract][Full Text] [Related]
13. Soluble Klotho is associated with mortality and cardiovascular events in hemodialysis.
Memmos E; Sarafidis P; Pateinakis P; Tsiantoulas A; Faitatzidou D; Giamalis P; Vasilikos V; Papagianni A
BMC Nephrol; 2019 Jun; 20(1):217. PubMed ID: 31185930
[TBL] [Abstract][Full Text] [Related]
14. Plasmatic Klotho and FGF23 Levels as Biomarkers of CKD-Associated Cardiac Disease in Type 2 Diabetic Patients.
Silva AP; Mendes F; Carias E; Gonçalves RB; Fragoso A; Dias C; Tavares N; Café HM; Santos N; Rato F; Leão Neves P; Almeida E
Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30934737
[TBL] [Abstract][Full Text] [Related]
15. Comparing the inflammatory profiles for incidence of diabetes mellitus and cardiovascular diseases: a prospective study exploring the 'common soil' hypothesis.
Bao X; Borné Y; Johnson L; Muhammad IF; Persson M; Niu K; Engström G
Cardiovasc Diabetol; 2018 Jun; 17(1):87. PubMed ID: 29895294
[TBL] [Abstract][Full Text] [Related]
16. Pro- and anti-inflammatory cytokines in post-infarction left ventricular remodeling.
Zarrouk-Mahjoub S; Zaghdoudi M; Amira Z; Chebi H; Khabouchi N; Finsterer J; Mechmeche R; Ghazouani E
Int J Cardiol; 2016 Oct; 221():632-6. PubMed ID: 27423081
[TBL] [Abstract][Full Text] [Related]
17. [MORPHOGENETIC PROTEINS--FIBROBLAST GROWTH FACTOR AND KLOTHO, IN THE SERA OF PATIENTS WITH CHRONIC RENAL DISEASE].
Milovanova LY; Kozlovskaya LV; Markina MM; Milovanova SY; Borisov AA; Mukhin NA; Fomin VV; Moiseev SV
Klin Med (Mosk); 2015; 93(12):32-8. PubMed ID: 27149811
[TBL] [Abstract][Full Text] [Related]
18. Soluble Klotho and Brain Atrophy in Alcoholism.
González-Reimers E; Romero-Acevedo L; Espelosín-Ortega E; Martín-González MC; Quintero-Platt G; Abreu-González P; José de-la-Vega-Prieto M; Martínez-Martínez D; Santolaria-Fernández F
Alcohol Alcohol; 2018 Sep; 53(5):503-510. PubMed ID: 29846497
[TBL] [Abstract][Full Text] [Related]
19. Soluble klotho and mortality: the Ludwigshafen Risk and Cardiovascular Health Study.
Brandenburg VM; Kleber ME; Vervloet MG; Larsson TE; Tomaschitz A; Pilz S; Stojakovic T; Delgado G; Grammer TB; Marx N; März W; Scharnagl H
Atherosclerosis; 2015 Oct; 242(2):483-9. PubMed ID: 26298739
[TBL] [Abstract][Full Text] [Related]
20. Impact of inflammatory markers on the relationship between sleep quality and incident cardiovascular events in type 2 diabetes.
Meng LL; Tang YZ; Ni CL; Yang M; Song HN; Wang G; Li YZ; Zhang M; Li DQ
J Diabetes Complications; 2015; 29(7):882-6. PubMed ID: 26190532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
